India Gestational Diabetes Market (2025-2031) | Outlook, Competitive Landscape, Companies, Segmentation, Share, Size & Revenue, Forecast, Industry, Value, Growth, Analysis, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Gestational Diabetes Market Revenues & Volume, 2021 & 2031F

3.3 India Gestational Diabetes Market - Industry Life Cycle

3.4 India Gestational Diabetes Market - Porter's Five Forces

3.5 India Gestational Diabetes Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.6 India Gestational Diabetes Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 India Gestational Diabetes Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.8 India Gestational Diabetes Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of gestational diabetes in India due to factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates.

4.2.2 Growing awareness about the importance of early detection and management of gestational diabetes among healthcare providers and pregnant women.

4.2.3 Government initiatives aimed at improving maternal and child health, which may include programs targeting gestational diabetes screening and management.

4.3 Market Restraints

4.3.1 Limited access to healthcare services and diagnostic facilities in rural areas, hindering timely diagnosis and management of gestational diabetes.

4.3.2 Socioeconomic factors such as poverty and lack of education leading to poor awareness and compliance with gestational diabetes management protocols.

4.3.3 Lack of standardized guidelines and protocols for the management of gestational diabetes across healthcare facilities in India.

6.1 India Gestational Diabetes Market, By Treatment

6.1.1 Overview and Analysis

6.1.2 India Gestational Diabetes Market Revenues & Volume, By Treatment, 2021- 2031F

6.1.3 India Gestational Diabetes Market Revenues & Volume, By Insulin, 2021- 2031F

6.1.4 India Gestational Diabetes Market Revenues & Volume, By SGLT-2 inhibitor, 2021- 2031F

6.1.5 India Gestational Diabetes Market Revenues & Volume, By Alpha-glucosidase inhibitor, 2021- 2031F

6.1.6 India Gestational Diabetes Market Revenues & Volume, By Other, 2021- 2031F

6.2 India Gestational Diabetes Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 India Gestational Diabetes Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 India Gestational Diabetes Market Revenues & Volume, By Parenteral, 2021- 2031F

6.2.4 India Gestational Diabetes Market Revenues & Volume, By Other, 2021- 2031F

6.3 India Gestational Diabetes Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 India Gestational Diabetes Market Revenues & Volume, By Online Channel, 2021- 2031F

6.3.3 India Gestational Diabetes Market Revenues & Volume, By Offline Channel, 2021- 2031F

6.4 India Gestational Diabetes Market, By End-User

6.4.1 Overview and Analysis

6.4.2 India Gestational Diabetes Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 India Gestational Diabetes Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.4 India Gestational Diabetes Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7.1 India Gestational Diabetes Market Export to Major Countries

7.2 India Gestational Diabetes Market Imports from Major Countries

8.1 Percentage of pregnant women screened for gestational diabetes during antenatal care visits.

8.2 Average time taken from diagnosis to initiation of treatment for gestational diabetes.

8.3 Number of healthcare facilities offering specialized gestational diabetes management services.

8.4 Patient adherence rate to prescribed treatment and lifestyle modifications for gestational diabetes.

8.5 Incidence of adverse maternal and fetal outcomes associated with uncontrolled gestational diabetes.

9.1 India Gestational Diabetes Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.2 India Gestational Diabetes Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 India Gestational Diabetes Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.4 India Gestational Diabetes Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 India Gestational Diabetes Market Revenue Share, By Companies, 2024

10.2 India Gestational Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters